Cellectis Website Experiencing 404 Errors
Cellectis, a company developing gene editing cancer therapies, is experiencing page loading errors on its official website. Visitors are unable to access certain sections of the site.

Cellectis, a biopharmaceutical company focused on gene editing technologies for cancer treatments, is encountering 404 errors across various sections of its website. These errors prevent users from accessing important information about the company's operations and development pipeline.
The issues affect links related to the company's scientific platform, including details on its TALEN® technology and internal manufacturing capabilities. Additionally, information regarding the company's product candidates and investor relations materials appear to be inaccessible.
Key sections such as 'About Us,' which typically details the company's mission, governance, and partnerships, are also impacted. The 'Careers' section, which lists job opportunities and company culture, shows broken links as well.
While basic navigation and contact information on the Cellectis website remain functional, the widespread 404 errors suggest a significant technical problem impacting the accessibility of detailed corporate and scientific information.